Sorafenib and Oleanolic Acid - a promising approach to overcome chemotherapy resistance in Hepatocellular Carcinoma (HCC)

被引：0
|
作者：
Lange, M. [1 ]
Abhari, B. Ahangarian [2 ]
Bechstein, W. O. [1 ]
Fulda, S. [2 ,3 ,4 ]
Liese, J. [1 ,2 ,3 ,4 ]
机构：
[1] Goethe Univ Frankfurt, Gen & Visceral Surg, D-60054 Frankfurt, Germany
[2] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60054 Frankfurt, Germany
[3] German Canc Consortium DKTK, Heidelberg, Germany
[4] German Canc Res Ctr, Heidelberg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0525
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [1] Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy
    Kim, Dae Won
    Talati, Chetasi
    Kim, Richard
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (02) : 256 - 265
  • [2] The Enhanced Metastatic Potential of Hepatocellular Carcinoma (HCC) Cells with Sorafenib Resistance
    Chow, Ariel Ka-Man
    Ng, Lui
    Lam, Colin Siu-Chi
    Wong, Sunny Kit-Man
    Wan, Timothy Ming-Hun
    Cheng, Nathan Shiu-Man
    Yau, Thomas Chung-Cheung
    Poon, Ronnie Tung-Ping
    Pang, Roberta Wen-Chi
    PLOS ONE, 2013, 8 (11):
  • [3] A Fluorene Derivative, Induces Apoptosis and Ferroptosis to Overcome Sorafenib Resistance in Hepatocellular Carcinoma
    Tsai, Yiching
    Chiu, Chienchih
    Chang, Mengyang
    Chang, Wentsan
    CANCER SCIENCE, 2024, 115 : 956 - 956
  • [4] How to overcome multidrug resistance in chemotherapy for advanced hepatocellular carcinoma
    Ryu, Soo Hyung
    Chung, Young-Hwa
    LIVER INTERNATIONAL, 2010, 30 (04) : 496 - 498
  • [5] New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies
    Niu, Leilei
    Liu, Liping
    Yang, Shengli
    Ren, Jianwei
    Lai, Paul B. S.
    Chen, George G.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2017, 1868 (02): : 564 - 570
  • [6] TNF-alpha is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
    Tan, Wenliang
    Luo, Xuan
    Li, Wenda
    Zhong, Jinyi
    Cao, Jun
    Zhu, Sicong
    Chen, Xianqing
    Zhou, Rui
    Shang, Changzhen
    Chen, Yajin
    EBIOMEDICINE, 2019, 40 : 446 - 456
  • [7] GPAT3 is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
    Zhou, Yu
    Zhao, Huakan
    Ren, Ran
    Zhou, Mingyue
    Zhang, Jiangang
    Wu, Zhijuan
    Chen, Yu
    Lei, Juan
    Chen, Yang
    Yu, Ying
    Li, Yongsheng
    THERANOSTICS, 2024, 14 (09): : 3470 - 3485
  • [8] Oleanolic acid encapsulated in liposomes as a potential therapeutic approach for hepatocellular carcinoma
    Macasoi, I.
    Pinzaru, I.
    Dorina, C.
    Cabuta, M.
    Marcovici, I.
    Cretu, O. M.
    Dehelean, C. A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 : S63 - S63
  • [9] Vinorelbine Improves the Efficacy of Sorafenib against Hepatocellular Carcinoma: A Promising Therapeutic Approach
    Ng, Wai Har
    Soo, Khee Chee
    Huynh, Hung
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [10] Resistance to Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma (HCC): Clinical Implications and Potential Strategies to Overcome the Resistance
    Ermi, Ali Gawi
    Sarkar, Devanand
    CANCERS, 2024, 16 (23)
12345